Synthetic oligodeoxynucleotide purification by polymerization of failure sequences

Area of Science:

• Biochemistry
• Organic Chemistry
• Medicinal Chemistry

Background:

• Oligodeoxynucleotides are crucial therapeutic agents.
• Current purification methods for synthetic oligodeoxynucleotides face challenges in scalability and efficiency.
• Failure sequences in oligonucleotide synthesis can compromise final product purity and yield.

Purpose of the Study:

• To develop an efficient and scalable method for purifying synthetic oligodeoxynucleotides.
• To address the issue of failure sequences in oligonucleotide synthesis.
• To facilitate the large-scale production of oligonucleotide-based therapeutics.

Main Methods:

• Synthetic oligodeoxynucleotides were purified using a capping strategy.
• Acrylated phosphoramidite was employed to cap failure sequences.
• Subsequent polymerization and product extraction were performed to isolate the purified oligonucleotide.

Main Results:

• The capping method effectively removed failure sequences from synthetic oligodeoxynucleotides.
• The polymerization and extraction steps yielded purified oligonucleotide products.
• The developed method demonstrated suitability for large-scale purification processes.

Conclusions:

• The novel capping approach provides an efficient means to purify synthetic oligodeoxynucleotides.
• This method is advantageous for the large-scale purification of oligonucleotide drugs.
• The findings support the advancement of oligonucleotide-based drug manufacturing.